Imaan Khan

Imaan Khan has a wealth of experience in clinical research and healthcare. Imaan began in 2014 as a Research Assistant at DePaul University, where they conducted coding for adolescent interviews to understand how stressful life experiences affect the mental and physical health and academic engagement and achievement of youth. Imaan then joined Behavioral Health Care Associates as a TMS Technician, Lead Clinical Research Coordinator, and Rapid Detox Administrator. In this role, they obtained informed consent from patients for Rapid Opiate Detox Treatment, processed payments, conducted Rapid Detox Treatment, administered medication, monitored and reported detox patient's vital signs, and provided appropriate aftercare and follow up for patients who completed treatment. In 2016, Imaan Khan moved to Georgetown Lombardi Comprehensive Cancer Center as a Hematology/Oncology Clinical Research Coordinator. Two years later, they joined Maryland Oncology as a Hematology/Oncology Clinical Research Coordinator. In 2020, Imaan Khan joined OncoImmune, Inc. as a Clinical Research Associate and OncoC4, Inc. as a Senior Clinical Research Associate and Lead Clinical Research Associate.

Imaan Khan attended Windsor University School of Medicine from 2006 to 2013, where they obtained their Doctor of Medicine (MD) degree in Medicine. In October 2014, they also obtained a certification as a Transcranial Magnetic Stimulation Technician.